Peripheral Blood Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone MarrowGraft vs Host DiseaseLeukapheresisBone Marrow CellsGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsStem CellsBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsMelphalanTissue DonorsCyclophosphamideGraft SurvivalCombined Modality TherapyBone and BonesMultiple MyelomaStem Cell TransplantationBlood CellsBusulfanAntineoplastic Combined Chemotherapy ProtocolsBone Marrow DiseasesBlood Cell CountHematopoiesisCord Blood Stem Cell TransplantationTreatment OutcomeBlood DonorsBone Marrow PurgingLymphoma, Non-HodgkinEtoposideAntineoplastic Agents, AlkylatingMyeloablative AgonistsTransplantation ChimeraRecurrenceThiotepaWhole-Body IrradiationHistocompatibilityRemission InductionLeukemiaColony-Forming Units AssayHistocompatibility TestingFlow CytometryCell DifferentiationPlatelet CountCell SeparationTime FactorsIfosfamideAnemia, AplasticCells, CulturedImmunophenotypingEmbryonic Stem CellsCytarabineDisease-Free SurvivalLeukocytes, MononuclearLeukocyte CountInfectionRecombinant ProteinsTransplantation, IsogeneicAdult Stem CellsLeukemia, Myeloid, AcuteVidarabineRetrospective StudiesBone RemodelingPOEMS SyndromeImmunosuppressive AgentsVincristineSalvage TherapySurvival RateImmunomagnetic SeparationBone Marrow ExaminationAntigens, CDHodgkin DiseaseStem Cell FactorT-LymphocytesLymphomaSurvival AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow NeoplasmsNeoplasmsCarmustineMyelodysplastic SyndromesLymphocyte DepletionGranulocytesHematologic DiseasesPlatelet TransfusionProchlorperazineLeukocyte TransfusionPluripotent Stem CellsGranulocyte-Macrophage Colony-Stimulating FactorCell CountAmyloidosisStem Cell NicheFeasibility Studies